Vepesid · DIN 00616192 · 50 mg · capsule
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Vepesid · DIN 00616192
Manufacturer: Cheplapharm Arzneimittel GmbH; listing date 1996-10-01
Health Canada: Marketed since 2020-01-02 · brand VEPESID · ATC L01CB01 ETOPOSIDE · form Capsule · route Oral · ingredients ETOPOSIDE 50 MG · company Biomed · schedule Prescription
Vepesid: Formulary list price $48.76 per unit (the source does not state the unit; exact figure $48.7570). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00616192)
Source record
DIN 00616192: Vepesid
Raw flags: sec3=Y
Item: 100000072; group id 158; item number 0271; lccId None; manufacturer id CHE
Source form: Cap; strength: 50mg
Recorded listing: General benefit
Source prices (unrounded): $48.7570; ministry $48.7570
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00616192
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5963
Shortage status: not checked (no credentials)